Cellosaurus logo
expasy logo

Cellosaurus Mel Cher (CVCL_B6K8)

[Text version]
Cell line name Mel Cher
Synonyms mel Cher
Accession CVCL_B6K8
Resource Identification Initiative To cite this cell line use: Mel Cher (RRID:CVCL_B6K8)
Comments Group: Patented cell line.
Registration: Non-internationally recognized Depositary Authority, Russian Cell Culture Collection (RCCC); 704D.
Derived from site: Metastatic; Lymph node; UBERON=UBERON_0000027.
Sequence variations
Disease Melanoma (NCIt: C3224)
Species of origin Homo sapiens (Human) (NCBI Taxonomy: 9606)
Hierarchy Children:
CVCL_B6K9 (Mel Cher 5C)
Sex of cell Male
Category Cancer cell line
Publications

PubMed=16107020
Mikhailova I.N., Lukashina M.I., Baryshnikov A.Y., Morozova L.F., Burova O.S., Palkina T.N., Kozlov A.M., Golubeva V.A., Cheremushkin E.A., Doroshenko M.B., Demidov L.V., Kiselev S.L., Larin S.S., Georgiev G.P.
Melanoma cell lines as the basis for antitumor vaccine preparation.
Vestn. Ross. Akad. Med. Nauk 2005:37-40(2005)

CLPUB00681
Berezhnoy A.E., Zakeyeva I.R., Kibardin A.V., Chernysheva A.D., Moiseyenko V.M., Danilov A.O., Demidov L.V., Baryshnikov A.Y., Gnuchev N.V., Georgiev G.P., Larin S.S.
Analysis of HLA-E expression in human melanoma cells.
Ross. Bioterap. Zh. 5:66-71(2006)

Patent=RU2364624
Mikhailova I.N., Baryshnikov A.Y., Demidov L.V., Kiselev S.L., Burova O.S., Morozova L.F.
Cell line of human melanoma mel Cher, used for obtaining anti-tumour vaccines.
Patent number RU2364624, 20-Aug-2009

Patent=RU2404243
Grigorieva I.N., Stepanova E.V., Vartanjan A.A., Baryshnikov A.Y., Mikhailova I.N., Morozova L.F., Burova O.S.
Application of human skin melanoma cell line mel Cher as positive model of vasculogenic mimicry.
Patent number RU2404243, 20-Nov-2010

CLPUB00680
Mikhailova I.N., Baryshnikov A.Y., Morozova L.F., Burova O.S., Shubina I.Z., Kovalevsky D.A., Voronina E.S., Treshalina H.M., Lushnikova A.A., Tsyganova I.V., Mazurenko N.N.
Human skin melanoma cell lines collection.
(In) Management of malignant melanoma; pp.1-6; SM Group; Dover (2016)

DOI=10.17650/1726-9784-2016-15-3-90-94
Morozova L.F., Suraeva N.M., Burova O.S., Barmashov A.E., Baryshnikova M.A.
Changes in the morphological and immunological characteristics of Mel Cher melanoma cells in response to low concentration of embryo calf serum.
Ross. Bioterap. Zh. 15:90-94(2016)

PubMed=27313776; DOI=10.3892/ol.2016.4523
Vartanian A.A., Karshieva S., Dombrovsky V., Belyavsky A.
Melanoma educates mesenchymal stromal cells towards vasculogenic mimicry.
Oncol. Lett. 11:4264-4268(2016)

PubMed=28881731; DOI=10.18632/oncotarget.17014
Emelyanova M., Ghukasyan L., Abramov I., Ryabaya O., Stepanova E.V., Kudryavtseva A., Sadritdinova A., Dzhumakova C., Belysheva T., Surzhikov S., Lyubchenko L., Zasedatelev A., Nasedkina T.
Detection of BRAF, NRAS, KIT, GNAQ, GNA11 and MAP2K1/2 mutations in Russian melanoma patients using LNA PCR clamp and biochip analysis.
Oncotarget 8:52304-52320(2017)

DOI=10.17650/1726-9784-2018-17-4-27-35
Mikhailova I.N., Treshalina E.M., Morozova L.F., Andronova N.V., Shubina I.Z., Lushnikova A.A.
Cell lines of human melanoma and their xenograft with BRAF or NRAS mutations a targets for targeted therapy.
Ross. Bioterap. Zh. 17:27-35(2018)

Cross-references
Cell line databases/resources cancercelllines; CVCL_B6K8
Encyclopedic resources Wikidata; Q112129263
Entry history
Entry creation17-Mar-2022
Last entry update05-Oct-2023
Version number5